Taytulla birth control pills recalled because they might not prevent pregnancy

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

MADISON, N.J. — Allergan is voluntarily recalling packs of its birth control pills in the U.S. because of a packaging error with placebos, increasing the possibility of unintended pregnancy.

The company says four placebo pills were placed out of order in the Taytulla packs. Allergan says the first four days of therapy had four non-hormonal placebo capsules instead of active capsules.

The recall involves lot 5620706, which expires in May 2019. Consumers who have those birth control pills should arrange to return them to their physicians.

Consumers with questions about the recall are being asked to contact Allergan at 800-678-1605, Monday through Friday.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.